COVID-19 Company Directory
The commercial organizations listed in this directory have announced they are conducting clinical research on treatment for COVID-19, often in association with academic partners. When available, contact information is included as are brief descriptions of the interventions being explored. Science is moving rapidly to address this global crisis, so new listings will be added as more companies and therapies move into clinical stages. Please feel free to check this directory often.
You may opt to further streamline your search by using the Stage and Type options. Simply click one or more of those boxes to refine your search. To find Clinical Trials and Expanded Access programs, please search here.
Grifols
Grifols completes development of very high sensitivity molecular test to detect SARS-CoV-2 virus - a specific TMA (Transcription-Mediated Amplification) molecular test that permits the detection of the SARS-CoV-2 virus in plasma, blood and respiratory samples.
Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19 - Grifols will collect plasma from convalescent COVID-19 patients, process this specific plasma into a hyperimmune globulin and support the necessary preclinical and clinical studies to determine if anti-SARS-CoV-2 hyperimmune globulin therapy can successfully be used to treat COVID-19 disease. This initiative is a result of a collaboration between Grifols, the U.S. Food and Drug Administration (FDA), the U.S. Biomedical Advanced Research Authority (BARDA), and other Federal health agencies.
People Who Have Recovered from COVID-19 Can Now Donate their Convalescent Plasma in select Grifols U.S. Plasma Donor Centers - Grifols has begun identifying, screening and selecting volunteer donors who have recovered from COVID-19 to donate their plasma in select U.S. cities. The plasma will be used to produce a hyperimmune globulin that, if proven effective, could potentially treat the disease.